Cellceutix Pharmaceuticals, Inc.
GPTKB entity
Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:focus |
antibiotics
oncology dermatology |
| gptkbp:foundedYear |
2007
|
| gptkbp:founder |
Dr. Krishna Menon
Leo Ehrlich |
| gptkbp:headquartersLocation |
gptkb:Beverly,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cellceutix Pharmaceuticals, Inc.
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:keyPerson |
Dr. Krishna Menon
Leo Ehrlich |
| gptkbp:product |
Brilacidin
Kevetrin Prurisol |
| gptkbp:renamed |
Innovation Pharmaceuticals Inc.
|
| gptkbp:tradedOn |
OTCQB: CTIX
|
| gptkbp:bfsParent |
gptkb:CTIX
|
| gptkbp:bfsLayer |
8
|